Literature DB >> 16447641

[Association between genetic polymorphisms in methylentetrahydrofolate reductase and risk of lung cancer].

Xue-mei Zhang1, Xiao-ping Miao, Wen Tan, Shi-ning Qu, Tong Sun, Yi-feng Zhou, Dong-xin Lin.   

Abstract

OBJECTIVE: To investigate the association between methylentetrahydrofolate reductase (MTHFR) polymorphisms and risk of lung cancer.
METHODS: Totally 505 cases with lung cancer and 500 frequency-matched controls were genotyped for the MTHFR C677T and A1298C polymorphisms by polymerase chain reaction-restriction fragment length polymorphism methods. The odds ratios (OR) and 95% confidence intervals (CI) were calculated using unconditional logistic regression model. Haplotype frequency was estimated using EH software.
RESULTS: The frequency of the MTHFR C677T allele in cases was significantly higher than that in controls (53.5% vs 44.9%, P < 0.001). Compared with the 677CC genotype, the 677CT and 677TT genotypes were associated with increased risk of lung cancer, with the OR being 1.43 (95% CI, 1.04-1.95) and 2.40 (95% CI, 1.61-3.59), respectively. In addition, a significant difference in the distribution of haplotype frequencies between cases and controls was observed.
CONCLUSION: Functional polymorphism in MTHFR is associated with increased risk of lung cancer in Chinese population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16447641

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  10 in total

1.  International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants.

Authors:  Therese Truong; Wiebke Sauter; James D McKay; H Dean Hosgood; Carla Gallagher; Christopher I Amos; Margaret Spitz; Joshua Muscat; Philip Lazarus; Thomas Illig; H Erich Wichmann; Heike Bickeböller; Angela Risch; Hendrik Dienemann; Zuo-Feng Zhang; Behnaz Pezeshki Naeim; Ping Yang; Shanbeh Zienolddiny; Aage Haugen; Loïc Le Marchand; Yun-Chul Hong; Jin Hee Kim; Eric J Duell; Angeline S Andrew; Chikako Kiyohara; Hongbing Shen; Keitaro Matsuo; Takeshi Suzuki; Adeline Seow; Daniel P K Ng; Qing Lan; David Zaridze; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Vali Constantinescu; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Neil E Caporaso; Demetrius Albanes; Michael Thun; Maria Teresa Landi; Joanna Trubicka; Marcin Lener; Jan Lubinski; Ying Wang; Amélie Chabrier; Paolo Boffetta; Paul Brennan; Rayjean J Hung
Journal:  Carcinogenesis       Date:  2010-01-27       Impact factor: 4.944

2.  Quantitative assessment of the effect of MTHFR polymorphisms on the risk of lung carcinoma.

Authors:  Yao Zhang; Guo Qiang Chen; Yong Ji; Bin Huang; Wei Sheng Shen; Li Chun Deng; Lei Xi; Xiang Ming Cao
Journal:  Mol Biol Rep       Date:  2012-01-04       Impact factor: 2.316

3.  Meta-analysis of methylenetetrahydrofolate reductase polymorphism and lung cancer risk in Chinese.

Authors:  Xin Wang; Kai Yue; Liran Hao
Journal:  Int J Clin Exp Med       Date:  2015-01-15

4.  Methylenetetrahydrofolate reductase gene polymorphisms and lung cancer: a meta-analysis.

Authors:  Renfang Mao; Yihui Fan; Yan Jin; Jing Bai; Songbin Fu
Journal:  J Hum Genet       Date:  2008-03-14       Impact factor: 3.172

5.  Meta-analysis on MTHFR polymorphism and lung cancer susceptibility in East Asian populations.

Authors:  Xue-DE Zhang; Yan-Ting Li; Shuan-Ying Yang; Wei Li
Journal:  Biomed Rep       Date:  2013-02-25

6.  Methylenetetrahydrofolate reductase C677T polymorphism in patients with lung cancer in a Korean population.

Authors:  Lian-Hua Cui; Min-Ho Shin; Hee Nam Kim; Hye-Rim Song; Jin-Mei Piao; Sun-Seog Kweon; Jin-Su Choi; Woo-Jun Yun; Young-Chul Kim; In-Jae Oh; Kyu-Sik Kim
Journal:  BMC Med Genet       Date:  2011-02-22       Impact factor: 2.103

7.  Methylenetetrahydrofolate reductase polymorphisms and interaction with smoking and alcohol consumption in lung cancer risk: a case-control study in a Japanese population.

Authors:  Chikako Kiyohara; Takahiko Horiuchi; Koichi Takayama; Yoichi Nakanishi
Journal:  BMC Cancer       Date:  2011-10-25       Impact factor: 4.430

8.  Methylenetetrahydrofolate reductase 677TT genotype may be associated with an increased lung cancer risk in North China: an updated meta-analysis.

Authors:  Nan-Bo Liu; Jun Li; Jia-Feng Qi; Zhen-Zhong Zhang; Xu Wu; Jun-Hua Zhang
Journal:  Med Sci Monit       Date:  2014-12-29

9.  Association between methylenetetrahydrofolate reductase (MTHFR) polymorphisms and lung cancer risk in Chinese people: An updated meta-analysis.

Authors:  Rui Zhong; Qingling Chen; Xinyue Zhang; Mengmeng Li; Xin Zhang; Weihong Lin
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

10.  Influence of methylenetetrahydrofolate reductase C677T polymorphism on the risk of lung cancer and the clinical response to platinum-based chemotherapy for advanced non-small cell lung cancer: an updated meta-analysis.

Authors:  Ning Zhu; Yi Gong; Jian He; Jingwen Xia; Xiaodong Chen
Journal:  Yonsei Med J       Date:  2013-11       Impact factor: 2.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.